Evidence map›Paper›PMID 22666499›Full record

ArticlePloS one2012

Molecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the Picovirinae.

Nikolay V Volozhantsev, Brian B Oakley, Cesar A Morales, Vladimir V Verevkin, Vasily A Bannov, Valentina M Krasilnikova, Anastasia V Popova, Eugeni L Zhilenkov, Johnna K Garrish, Kathleen M Schegg and 7 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Journal of virology · 2024
    Article
  4. Article
  5. Article
  6. Characterization and Genomic Analysis of a Novel Lytic Phage DCp1 againstInternational journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Novel Lytic Enzyme of Prophage Origin fromInternational journal of molecular sciences · 2021
    Article
  11. A Rare, VirulentPHAGE (New Rochelle, N.Y.) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Abundance of TwoFrontiers in microbiology · 2016
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Nikolay V VolozhantsevState Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow region, Russian Federation. nikvol@obolensk.org
Brian B Oakley
Cesar A Morales
Vladimir V Verevkin
Vasily A Bannov
Valentina M Krasilnikova
Anastasia V Popova
Eugeni L Zhilenkov
Johnna K Garrish
Kathleen M Schegg
Rebekah Woolsey
David R Quilici
J Eric Line
Kelli L Hiett
Gregory R Siragusa
Edward A Svetoch
Bruce S Seal
State Research Center for Applied Microbiology and Biotechnology · RUU.S. National Poultry Research Center · USUniversity of Nevada, Reno · USAgricultural Research Service · USDuPont (United States) · US

Funding

UNDERGRADUATE RESEARCH AND TRAININGP20RR016464 · NCRR · UNIVERSITY OF NEVADA RENO · PI LORICO, AURELIO · 2001 to 2011
$30.3M
Acquisition of a Hybrid LC/MS/MS to Enhance Research in NevadaS10RR023587 · NCRR · UNIVERSITY OF NEVADA RENO · PI QUILICI, DAVID ROGER · 2009 to 2009
$472k
NCRR NIH HHS #1S10 RR023587-01A2NCRR NIH HHS #P20 RR-016464NCRR NIH HHS P20 RR016464NCRR NIH HHS S10 RR023587
6 · The paper itself

Abstract

Clostridium perfringens is a Gram-positive, spore-forming anaerobic bacterium responsible for human food-borne disease as well as non-food-borne human, animal and poultry diseases. Because bacteriophages or their gene products could be applied to control bacterial diseases in a species-specific manner, they are potential important alternatives to antibiotics. Consequently, poultry intestinal material, soil, sewage and poultry processing drainage water were screened for virulent bacteriophages that lysed C. perfringens. Two bacteriophages, designated ΦCPV4 and ΦZP2, were isolated in the Moscow Region of the Russian Federation while another closely related virus, named ΦCP7R, was isolated in the southeastern USA. The viruses were identified as members of the order Caudovirales in the family Podoviridae with short, non-contractile tails of the C1 morphotype. The genomes of the three bacteriophages were 17.972, 18.078 and 18.397 kbp respectively; encoding twenty-six to twenty-eight ORF's with inverted terminal repeats and an average GC content of 34.6%. Structural proteins identified by mass spectrometry in the purified ΦCP7R virion included a pre-neck/appendage with putative lyase activity, major head, tail, connector/upper collar, lower collar and a structural protein with putative lysozyme-peptidase activity. All three podoviral bacteriophage genomes encoded a predicted N-acetylmuramoyl-L-alanine amidase and a putative stage V sporulation protein. Each putative amidase contained a predicted bacterial SH3 domain at the C-terminal end of the protein, presumably involved with binding the C. perfringens cell wall. The predicted DNA polymerase type B protein sequences were closely related to other members of the Podoviridae including Bacillus phage Φ29. Whole-genome comparisons supported this relationship, but also indicated that the Russian and USA viruses may be unique members of the sub-family Picovirinae.

Indexed as

Base SequenceClostridium perfringensGenome, ViralMolecular Sequence DataOpen Reading FramesPhylogenyPodoviridaeViral Nonstructural ProteinsViral Structural ProteinsVirionVirulenceViral Nonstructural ProteinsViral Structural Proteins

Identifiers

PMID22666499
PMCPMC3362512
OpenAlexW2130298607

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.